Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Recombinant AAV-2 harboring gfp-antisense/ribozyme fusion sequences monitor transduction, gene expression, and show anti-HIV-1 efficacy

Gene Therapy volume 6, pages 1231–1238 (1999)Cite this article

Abstract

Vector-mediated delivery of potentially antivirally active genes is a key step in somatic gene therapy including therapeutic approaches against AIDS. A crucial technical prerequisite is to monitor DNA transfer into target cells. Here, we describe recombinant infectious particles derived from the adeno-associated virus type 2 (AAV-2) that are suitable to deliver effective HIV-1-directed antisense and ribozyme genes into target cells. To monitor transduction, we designed and tested a number of fusions between indicator-coding sequences of luciferase or gfp with effective HIV-1-directed antisense or ribozyme sequences. The combination of an indicator function and an antiviral func- tion in cis allows successful identification of transduced cells and measurement of effects on the replication of HIV-1 in antisense/ribozyme-expressing cells only. The fusion genes were shown to express the indicator genes. Inhibition of HIV-1 replication mediated by the antisense/ribozyme portion of the fusion transcripts was similar to parental constructs and neither acute nor long-term toxicity of fusion genes and their gene products was observed. These results suggest the use of rAAV constructs described here as tools to study the transducibility of target cells, gene expression and efficacy of HIV-1-directed antisense and ribozyme genes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Muzyczka N . Use of adeno-associated virus as a general transduction vector for mammalian cells Curr Top Microbiol Immunol 1992 158: 97–129

    CAS  PubMed  Google Scholar 

  2. Kotin RM et al. Site-specific integration by adeno-associated virus Proc Natl Acad Sci USA 1990 87: 2211–2215

    Article  CAS  Google Scholar 

  3. de la Maza LM, Carter BJ . Molecular structure of adeno-associated virus variant DNA J Biol Chem 1980 255: 3194–3203

    CAS  PubMed  Google Scholar 

  4. Hermonat PL, Quirk JG, Bishop BM, Han L . The packaging capacity of adeno-associated virus (AAV) and the potential for wild-type-plus AAV gene therapy vectors FEBS Lett 1997 407: 78–84

    Article  CAS  Google Scholar 

  5. Dong JY, Fan PD, Frizzell RA . Quantitative analysis of the packaging capacity of recombinant adeno-associated virus Hum Gen Ther 1996 7: 2101–2112

    Article  CAS  Google Scholar 

  6. Halbert CL et al. Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration J Virol 1997 71: 5932–5941

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Conrad CK et al. Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung Gene Therapy 1996 3: 658–668

    CAS  PubMed  Google Scholar 

  8. Flotte TR et al. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector Proc Natl Acad Sci USA 1993 90: 10613–10617

    Article  CAS  Google Scholar 

  9. Kaplitt MG et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain Nat Genet 1994 8: 148–154

    Article  CAS  Google Scholar 

  10. Xiao X, Li J, Samulski RJ . Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector J Virol 1996 70: 8098–8108

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Ponnazhagan S, Yoder MC, Srivastava A . Adeno-associated virus type 2-mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo J Virol 1997 71: 3098–3104

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Wilson JM . Vectors – shuttle vehicles for gene therapy Clin Exp Immunol 1997 1: 31–32

    CAS  Google Scholar 

  13. Alexander IE, Russell DW, Spence AM, Miller AD . Effects of gamma irradiation on the transduction of dividing and nondividing cells in brain and muscle of rats by adeno-associated virus vectors Hum Gen Ther 1996 7: 841–850

    Article  CAS  Google Scholar 

  14. Peel AL et al. Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters Gene Therapy 1997 4: 16–24

    Article  CAS  Google Scholar 

  15. Miller JL et al. Recombinant adeno-associated virus (rAAV)-mediated expression of a human gamma-globin gene in human progenitor-derived erythroid cells (published erratum appears in Proc Natl Acad Sci USA 1995; 92: 646) Proc Natl Acad Sci USA 1994 91: 10183–10187

    Article  CAS  Google Scholar 

  16. Maass G et al. Recombinant adeno-associated virus for the generation of autologous, gene-modified tumor vaccines: evidence for a high transduction efficiency into primary epithelial cancer cells Hum Gen Ther 1998 9: 1049–1059

    Article  CAS  Google Scholar 

  17. Sczakiel G, Oppenländer M, Rittner K, Pawlita M . Tat- and Rev-directed antisense RNA expression inhibits and abolishes replication of the human immunodeficiency virus type 1: a temporal analysis J Virol 1992 66: 5576–5581

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Rittner K, Sczakiel G . Identification and analysis of antisense RNA target regions of the human immunodeficiency virus type 1 Nucleic Acids Res 1991 19: 1421–1426

    Article  CAS  Google Scholar 

  19. Homann M et al. Incorporation of the catalytic domain of a hammerhead ribozyme into antisense RNA enhances its inhibitory effect on the replication of human immunodeficiency virus type 1 Nucleic Acids Res 1993 21: 2809–2814

    Article  CAS  Google Scholar 

  20. Rittner K, Stöppler H, Pawlita M, Sczakiel G . Versatile eucaryotic vectors for strong and constitutive transient and stable gene expression Meth Mol Biol 1991 2: 176–181

    CAS  Google Scholar 

  21. Samulski RJ, Chang LS, Shenk T . A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication J Virol 1987 61: 3096–3101

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Grimm D, Kern A, Rittner K, Kleinschmidt JA . Novel tools for the production and purification of recombinant AAV vectors Hum Gen Ther 1998 10: 2745–2760

    Article  Google Scholar 

  23. Fisher KJ et al. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading strand synthesis J Virol 1996 70: 520–532

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Ponnazhagan S et al. Adeno-associated virus type 2-mediated transduction in primary human bone marrow-derived CD34+ hematopoietic progenitor cells: donor variation and correlation of transgene expression with cellular differentiation J Virol 1997 71: 8262–8267

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Alexander IE, Russell DW, Miller AD . Transfer of contaminants in adeno-associated virus vector stocks can mimic transduction and lead to artifactual results Hum Gen Ther 1997 8: 1911–1920

    Article  CAS  Google Scholar 

  26. Antoni BA et al. Adeno-associated virus Rep protein inhibits human immunodeficiency virus type 1 production in human cells J Virol 1991 65: 396–404

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Rittner K, Heilbronn R, Kleinschmidt JA, Sczakiel G . Adeno-associated virus type 2-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) replication: involvement of p78rep/p68rep and the HIV-1 long terminal repeat J Gen Virol 1992 73: 2977–2981

    Article  CAS  Google Scholar 

  28. Mendelson E et al. Replication of adeno-associated virus type 2 in human lymphocytic cells and interaction with HIV-1 Virology 1992 187: 453–463

    Article  CAS  Google Scholar 

  29. Oelze I, Rittner K, Sczakiel G . Adeno-associated virus type 2 rep gene-mediated inhibition of basal gene expression of human immunodeficiency virus type 1 involves its negative regulatory functions J Virol 1994 68: 1229–1233

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Chatterjee S, Johnson PR, Wong KKJ . Dual-target inhibition of HIV-1 in vitro by means of adeno-associated virus antisense vector Science 1992 258: 1485–1488

    Article  CAS  Google Scholar 

  31. Chen JD et al. Intra- and extracellular immunization against HIV-1 infection with lymphocytes transduced with an AAV vector expressing a human anti-gp 120 antibody Hum Gen Ther 1996 7: 1515–1525

    Article  CAS  Google Scholar 

  32. Harada S, Koyanagi Y, Yamamoto N . Infection of HTLV-III/LAV in HTLV-1-carrying cells MT-2 and MT-4 and application in a plaque assay Science 1985 229: 563–566

    Article  CAS  Google Scholar 

  33. Gey GO, Coffman WD, Kubicek MT . Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium Cancer Res 1952 12: 264–265

    Google Scholar 

  34. Leibovitz A et al. Classification of human colorectal adenocarcinoma cell lines Cancer Res 1976 36: 4562–4569

    CAS  PubMed  Google Scholar 

  35. Pleskoff O et al. Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry (see comments) Science 1997 276: 1874–1878

    Article  CAS  Google Scholar 

  36. DuBridge RB et al. Analysis of mutation in human cells by using an Epstein–Barr virus shuttle system Mol Cell Biol 1987 7: 379–387

    Article  CAS  Google Scholar 

  37. Adachi A et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone J Virol 1986 59: 284–291

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Srivastava A, Lusby EW, Berns KI . Nucleotide sequence and organization of the adeno-associated virus 2 genome J Virol 1983 45: 555–564

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Chen C, Okayama H . High-efficiency transformation of mammalian cells by plasmid DNA Mol Cell Biol 1987 7: 2745–2752

    Article  CAS  Google Scholar 

  40. Snyder RO, Xiao X, Samulski RJ . Production of recombinant adeno-associated viral vectors. In: Fracopoli N (eds) Current Protocols in Human Genetics John Wiley and Sons: New York, NY 1996 pp 12.1.1–12.1.23

    Google Scholar 

  41. Hunt SV . Preparation of lymphocytes and accessory cells. In: Klaus CGB (ed) Lymphocytes: a Practical Approach IRL Press Limited: Oxford 1987 pp 1–34

    Google Scholar 

Download references

Acknowledgements

We thank M Pförsich and R Haas for providing us with cell material as well as M Dittmar and H-G Kräusslich for supporting HIV-1 inhibition studies.

Author information

Authors and Affiliations

  1. Deutsches Krebsforschungszentrum, Forschungsschwerpunkt Angewandte Tumorvirologie, Im Neuenheimer Feld 242, Heidelberg, 69120, Germany

    A Hörster, B Teichmann, R Hormes, D Grimm, J Kleinschmidt & G Sczakiel

Authors
  1. A Hörster
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B Teichmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R Hormes
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D Grimm
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J Kleinschmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G Sczakiel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hörster, A., Teichmann, B., Hormes, R. et al. Recombinant AAV-2 harboring gfp-antisense/ribozyme fusion sequences monitor transduction, gene expression, and show anti-HIV-1 efficacy. Gene Ther 6, 1231–1238 (1999). https://doi.org/10.1038/sj.gt.3300955

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3300955

Keywords

This article is cited by

Search

Advanced search

Quick links